Cencora to Acquire American Oncology Network

07:54 AM EDT, 10/21/2026 (MT Newswires) -- Cencora (COR) said Wednesday it has signed a definitive agreement to acquire American Oncology Network in a deal that values the company at an enterprise value of $2.4 billion. The enterprise value consists of $2.3 billion at closing and contingent value rights of up to $100 million. Certain AON shareholders can participate in an equity rollover representing up to 25% of AON, Cencora said. Assuming those shareholders retain 25% of AON through the equity rollover, Cencora expects to pay about $1.7 billion to increase its ownership stake in the company to 75%, it said. Cencora also updated its adjusted diluted earnings per share guidance for fiscal year 2026 to at least $17.90, at the high end of its previous guidance range of $17.75 to $17.95.